Differential effect of transient global ischaemia on the levels of γ-aminobutyric acid type A (GABAA) receptor subunit mRNAs in young and older rats

Neuropathology and Applied Neurobiology

Volumn 38, Issue 7, 2012, Pages 710-722

  Montori, S ^a   Dos Anjos, S ^a   Poole, A ^d   Regueiro Purrinos M M ^b   Llorente, I L ^a   Darlison, M G ^d   Fernandez Lopez A ^a   Martinez Villayandre B ^c  

^a Instituto de Biomedicina   (Spain)

^b Área de Medicina y Cirugía Animal   (Spain)

^c UNIVERSITY OF LEÓN   (Spain)

^d EDINBURGH NAPIER UNIVERSITY   (United Kingdom)

Author keywords

Age; Cerebral ischaemia; GABAA receptor; GAD65; Meloxicam

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; GLUTAMATE DECARBOXYLASE 65; MELOXICAM; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; CAUDATE NUCLEUS; CONTROLLED STUDY; DENTATE GYRUS; GENE EXPRESSION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RAT; TRANSIENT GLOBAL ISCHEMIA; TREATMENT RESPONSE;

AGE FACTORS; AGING; ANIMALS; GENE EXPRESSION; HIPPOCAMPUS; ISCHEMIC ATTACK, TRANSIENT; MALE; PROTEIN SUBUNITS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; RNA, MESSENGER; THIAZINES; THIAZOLES;

EID: 84869117243     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2012.01254.x     Document Type: Article

References (87)

1. Simon J, Wakimoto H, Fujita N, Lalande M, Barnard EA. Analysis of the set of GABA(A) receptor genes in the human genome. J Biol Chem 2004; 279: 41422-35
2. Whiting PJ. GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery? Drug Discov Today 2003; 8: 445-50
3. Olsen RW, Sieghart W. International union of pharmacology. LXX. subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. update. Pharmacol Rev 2008; 60: 243-60
4. Pirker S, Schwarzer C, Wieselthaler A, Sieghart W, Sperk G. GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 2000; 101: 815-50
5. Laurie DJ, Wisden W, Seeburg PH. The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development. J Neurosci 1992; 12: 4151-72
6. Reynolds DS. The value of genetic and pharmacological approaches to understanding the complexities of GABA(A) receptor subtype functions: the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 2008; 90: 37-42
7. Olsen RW, Sieghart W. GABA A receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology 2009; 56: 141-8
8. Lee JM, Zipfel GJ, Choi DW. The changing landscape of ischaemic brain injury mechanisms. Nature 1999; 399: A7-14
9. Nishizawa Y. Glutamate release and neuronal damage in ischemia. Life Sci 2001; 69: 369-81
10. Arundine M, Tymianski M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci 2004; 61: 657-68
11. Costa C, Leone G, Saulle E, Pisani F, Bernardi G, Calabresi P. Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia. Stroke 2004; 35: 596-600
12. Schwartz-Bloom RD, Sah R. Gamma-aminobutyric acid(A) neurotransmission and cerebral ischemia. J Neurochem 2001; 77: 353-71
13. Zhang L, Hsu JC, Takagi N, Gurd JW, Wallace MC, Eubanks JH. Transient global ischemia alters NMDA receptor expression in rat hippocampus: correlation with decreased immunoreactive protein levels of the NR2A/2B subunits, and an altered NMDA receptor functionality. J Neurochem 1997; 69: 1983-94
14. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 1982; 239: 57-69
15. Pulsinelli WA. Selective neuronal vulnerability: morphological and molecular characteristics. Prog Brain Res 1985; 63: 29-37
16. Freund TF, Buzsaki G, Leon A, Baimbridge KG, Somogyi P. Relationship of neuronal vulnerability and calcium binding protein immunoreactivity in ischemia. Exp Brain Res 1990; 83: 55-66
17. Schmidt-Kastner R, Freund TF. Selective vulnerability of the hippocampus in brain ischemia. Neuroscience 1991; 40: 599-636
18. Sugawara T, Fujimura M, Morita-Fujimura Y, Kawase M, Chan PH. Mitochondrial release of cytochrome c corresponds to the selective vulnerability of hippocampal CA1 neurons in rats after transient global cerebral ischemia. J Neurosci 1999; 19: RC39
19. Yang G, Kitagawa K, Ohtsuki T, Kuwabara K, Mabuchi T, Yagita Y, Takazawa K, Tanaka S, Yanagihara T, Hori M, Matsumoto M. Regional difference of neuronal vulnerability in the murine hippocampus after transient forebrain ischemia. Brain Res 2000; 870: 195-8
20. Ikegaya Y, Matsuki N. Regionally selective neurotoxicity of NMDA and colchicine is independent of hippocampal neural circuitry. Neuroscience 2002; 113: 253-6
21. Dos-Anjos S, Martinez-Villayandre B, Montori S, Regueiro-Purrinos MM, Gonzalo-Orden JM, Fernandez-Lopez A. Transient global ischemia in rat brain promotes different NMDA receptor regulation depending on the brain structure studied. Neurochem Int 2009; 54: 180-5
22. Yager JY, Thornhill JA. The effect of age on susceptibility to hypoxic-ischemic brain damage. Neurosci Biobehav Rev 1997; 21: 167-74
23. Canese R, Lorenzini P, Fortuna S, Volpe MT, Giannini M, Podo F, Michalek H. Age-dependent MRI-detected lesions at early stages of transient global ischemia in rat brain. MAGMA 2004; 17: 109-16
24. Xu J, Liu Y, Zhang GY. Neuroprotection of GluR5-containing kainate receptor activation against ischemic brain injury through decreasing tyrosine phosphorylation of N-methyl-D-aspartate receptors mediated by src kinase. J Biol Chem 2008; 283: 29355-66
25. Liu Y, Wong TP, Aarts M, Rooyakkers A, Liu L, Lai TW, Wu DC, Lu J, Tymianski M, Craig AM, Wang YT. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J Neurosci 2007; 27: 2846-57
26. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, Olney JW. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999; 283: 70-4
27. Kemp JA, McKernan RM. NMDA receptor pathways as drug targets. Nat Neurosci 2002; 5 (Suppl.): 1039-42
28. Green AR, Hainsworth AH, Jackson DM. GABA potentiation: a logical pharmacological approach for the treatment of acute ischaemic stroke. Neuropharmacology 2000; 39: 1483-94
29. Calabresi P, Cupini LM, Centonze D, Pisani F, Bernardi G. Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia. Ann Neurol 2003; 53: 693-702
30. Allen NJ, Rossi DJ, Attwell D. Sequential release of GABA by exocytosis and reversed uptake leads to neuronal swelling in simulated ischemia of hippocampal slices. J Neurosci 2004; 24: 3837-49
31. Buddhala C, Hsu CC, Wu JY. A novel mechanism for GABA synthesis and packaging into synaptic vesicles. Neurochem Int 2009; 55: 9-12
32. Bu DF, Erlander MG, Hitz BC, Tillakaratne NJ, Kaufman DL, Wagner-McPherson CB, Evans GA, Tobin AJ. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci U S A 1992; 89: 2115-19
33. Martin DL, Rimvall K. Regulation of gamma-aminobutyric acid synthesis in the brain. J Neurochem 1993; 60: 395-407
34. Kaufman DL, Houser CR, Tobin AJ. Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J Neurochem 1991; 56: 720-3
35. Benson DL, Cohen PA. Activity-independent segregation of excitatory and inhibitory synaptic terminals in cultured hippocampal neurons. J Neurosci 1996; 16: 6424-32
36. Kanaani J, Lissin D, Kash SF, Baekkeskov S. The hydrophilic isoform of glutamate decarboxylase, GAD67, is targeted to membranes and nerve terminals independent of dimerization with the hydrophobic membrane-anchored isoform, GAD65. J Biol Chem 1999; 274: 37200-9
37. Eccles JC, Schmidt R, Willis WD. Pharmacological studies on presynaptic inhibition. J Physiol 1963; 168: 500-30
38. Rudomin P, Engberg I, Jimenez I. Mechanisms involved in presynaptic depolarization of group I and rubrospinal fibers in cat spinal cord. J Neurophysiol 1981; 46: 532-48
39. Kullmann DM, Ruiz A, Rusakov DM, Scott R, Semyanov A, Walker MC. Presynaptic, extrasynaptic and axonal GABAA receptors in the CNS: where and why? Prog Biophys Mol Biol 2005; 87: 33-46
40. Nusser Z, Sieghart W, Somogyi P. Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J Neurosci 1998; 18: 1693-703
41. Iqbal S, Baziany A, Gordon S, Wright S, Hussain M, Miyashita H, Shuaib A, Hasan Rajput A. Neuroprotective effect of tiagabine in transient forebrain global ischemia: an in vivo microdialysis, behavioral, and histological study. Brain Res 2002; 946: 162-70
42. Sternau LL, Lust WD, Ricci AJ, Ratcheson R. Role for gamma-aminobutyric acid in selective vulnerability in gerbils. Stroke 1989; 20: 281-7
43. Shuaib A, Mazagri R, Ijaz S. GABA agonist 'muscimol' is neuroprotective in repetitive transient forebrain ischemia in gerbils. Exp Neurol 1993; 123: 284-8
44. Chen Xu W, Yi Y, Qiu L, Shuaib A. Neuroprotective activity of tiagabine in a focal embolic model of cerebral ischemia. Brain Res 2000; 874: 75-7
45. Schwartz-Bloom RD, Miller KA, Evenson DA, Crain BJ, Nadler JV. Benzodiazepines protect hippocampal neurons from degeneration after transient cerebral ischemia: an ultrastructural study. Neuroscience 2000; 98: 471-84
46. Zhang F, Li C, Wang R, Han D, Zhang QG, Zhou C, Yu HM, Zhang GY. Activation of GABA receptors attenuates neuronal apoptosis through inhibiting the tyrosine phosphorylation of NR2A by src after cerebral ischemia and reperfusion. Neuroscience 2007; 150: 938-49
47. Galeffi F, Sinnar S, Schwartz-Bloom RD. Diazepam promotes ATP recovery and prevents cytochrome c release in hippocampal slices after in vitro ischemia. J Neurochem 2000; 75: 1242-9
48. Elsersy H, Mixco J, Sheng H, Pearlstein RD, Warner DS. Selective gamma-aminobutyric acid type A receptor antagonism reverses isoflurane ischemic neuroprotection. Anesthesiology 2006; 105: 81-90
49. Li Y, Lei Z, Xu ZC. Enhancement of inhibitory synaptic transmission in large aspiny neurons after transient cerebral ischemia. Neuroscience 2009; 159: 670-81
50. Li H, Siegel RE, Schwartz RD. Rapid decline of GABAA receptor subunit mRNA expression in hippocampus following transient cerebral ischemia in the gerbil. Hippocampus 1993; 3: 527-37
51. Schiene K, Bruehl C, Zilles K, Qu M, Hagemann G, Kraemer M, Witte OW. Neuronal hyperexcitability and reduction of GABAA-receptor expression in the surround of cerebral photothrombosis. J Cereb Blood Flow Metab 1996; 16: 906-14
52. Inglefield JR, Wilson CA, Schwartz-Bloom RD. Effect of transient cerebral ischemia on gamma-aminobutyric acidA receptor alpha 1-subunit-immunoreactive interneurons in the gerbil CA1 hippocampus. Hippocampus 1997; 7: 511-23
53. Qu M, Buchkremer-Ratzmann I, Schiene K, Schroeter M, Witte OW, Zilles K. Bihemispheric reduction of GABAA receptor binding following focal cortical photothrombotic lesions in the rat brain. Brain Res 1998; 813: 374-80
54. Han D, Zhang QG, Yong-Liu LC, Zong YY, Yu CZ, Wang W, Yan JZ, Zhang GY. Co-activation of GABA receptors inhibits the JNK3 apoptotic pathway via the disassembly of the GluR6-PSD95-MLK3 signaling module in cerebral ischemic-reperfusion. FEBS Lett 2008; 582: 1298-306
55. Qi SH, Liu Y, Wang WW, Wang M, Zhang GY. Neuroprotection of ethanol against cerebral ischemia/reperfusion induced brain injury through GABA receptor activation. Brain Res 2009; 1276: 151-8
56. Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT. Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J 2009; 276: 13-26
57. Barone FC, Feuerstein GZ. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 1999; 19: 819-34
58. Chamorro A, Hallenbeck J. The harms and benefits of inflammatory and immune responses in vascular disease. Stroke 2006; 37: 291-3
59. Feuerstein GZ, Wang X, Barone FC. Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets. Ann N Y Acad Sci 1997; 825: 179-93
60. Rodriguez-Yanez M, Castillo J. Role of inflammatory markers in brain ischemia. Curr Opin Neurol 2008; 21: 353-7
61. Kriz J. Inflammation in ischemic brain injury: timing is important. Crit Rev Neurobiol 2006; 18: 145-57
62. Taoufik E, Probert L. Ischemic neuronal damage. Curr Pharm Des 2008; 14: 3565-73
63. Antezana DF, Clatterbuck RE, Alkayed NJ, Murphy SJ, Anderson LG, Frazier J, Hurn PD, Traystman RJ, Tamargo RJ. High-dose ibuprofen for reduction of striatal infarcts during middle cerebral artery occlusion in rats. J Neurosurg 2003; 98: 860-6
64. Cole DJ, Patel PM, Reynolds L, Drummond JC, Marcantonio S. Temporary focal cerebral ischemia in spontaneously hypertensive rats: the effect of ibuprofen on infarct volume. J Pharmacol Exp Ther 1993; 266: 1713-17
65. Mehta SL, Manhas N, Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev 2007; 54: 34-66
66. Nogawa S, Zhang F, Ross ME, Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 1997; 17: 2746-55
67. Nogawa S, Forster C, Zhang F, Nagayama M, Ross ME, Iadecola C. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci U S A 1998; 95: 10966-71
68. Montori S, Dos-Anjos S, Martinez-Villayandre B, Regueiro-Purrinos MM, Gonzalo-Orden JM, Ruano D, Fernandez-Lopez A. Age and meloxicam attenuate the ischemia/reperfusion-induced down-regulation in the NMDA receptor genes. Neurochem Int 2010; 56: 878-85
69. Bendel O, Alkass K, Bueters T, von Euler M, von Euler G. Reproducible loss of CA1 neurons following carotid artery occlusion combined with halothane-induced hypotension. Brain Res 2005; 1033: 135-42
70. Vela J, Vitorica J, Ruano D. Rapid PCR-mediated synthesis of competitor molecules for accurate quantification of beta(2) GABA(A) receptor subunit mRNA. Brain Res Brain Res Protoc 2001; 8: 184-90
71. Imbeaud S, Graudens E, Boulanger V, Barlet X, Zaborski P, Eveno E, Mueller O, Schroeder A, Auffray C. Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids Res 2005; 33: e56
72. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001; 25: 402-8
73. Dalezios Y, Matsokis N. Brain benzodiazepine binding in aged rats. Neurochem Int 1998; 32: 213-17
74. Sugimoto A, Takeda A, Kogure K, Onodera H. NMDA receptor (NMDAR1) expression in the rat hippocampus after forebrain ischemia. Neurosci Lett 1994; 170: 39-42
75. Dos-Anjos S, Martinez-Villayandre B, Montori S, Regueiro-Purrinos MM, Gonzalo-Orden JM, Fernandez-Lopez A. Global ischemia-induced modifications in the expression of AMPA receptors and inflammation in rat brain. Brain Res 2009; 1287: 20-7
76. Montori S, Dos Anjos S, Rios-Granja MA, Perez-Garcia CC, Fernandez-Lopez A, Martinez-Villayandre B. AMPA receptor downregulation induced by ischaemia/reperfusion is attenuated by age and blocked by meloxicam. Neuropathol Appl Neurobiol 2010; 36: 436-47
77. Shimazaki K, Ishida A, Rhee SG, Takenawa T, Kawai N. Changes in IP3 3-kinase immunoreactivity following transient ischaemia in gerbil hippocampus. Neuroreport 1994; 5: 785-8
78. Meller R, Minami M, Cameron JA, Impey S, Chen D, Lan JQ, Henshall DC, Simon RP. CREB-mediated bcl-2 protein expression after ischemic preconditioning. J Cereb Blood Flow Metab 2005; 25: 234-46
79. Choi JS, Kim HY, Cha JH, Lee MY. Ischemic preconditioning-induced activation of ERK1/2 in the rat hippocampus. Neurosci Lett 2006; 409: 187-91
80. Zhang QG, Wang RM, Han D, Yang LC, Li J, Brann DW. Preconditioning neuroprotection in global cerebral ischemia involves NMDA receptor-mediated ERK-JNK3 crosstalk. Neurosci Res 2009; 63: 205-12
81. Saji M, Cohen M, Blau AD, Wessel TC, Volpe BT. Transient forebrain ischemia induces delayed injury in the substantia nigra reticulata: degeneration of GABA neurons, compensatory expression of GAD mRNA. Brain Res 1994; 643: 234-44
82. Yao H, Sadoshima S, Ooboshi H, Sato Y, Uchimura H, Fujishima M. Age-related vulnerability to cerebral ischemia in spontaneously hypertensive rats. Stroke 1991; 22: 1414-18
83. Small DL, Morley P, Buchan AM. Biology of ischemic cerebral cell death. Prog Cardiovasc Dis 1999; 42: 185-207
84. Ooboshi H, Ibayashi S, Takada J, Kumai Y, Iida M. Brain ischemia as a potential target of gene therapy. Exp Gerontol 2003; 38: 183-7
85. Ginsberg MD. Adventures in the pathophysiology of brain ischemia: penumbra, gene expression, neuroprotection: the 2002 Thomas Willis lecture. Stroke 2003; 34: 214-23
86. Back T, Hemmen T, Schuler OG. Lesion evolution in cerebral ischemia. J Neurol 2004; 251: 388-97
87. Toscano CD, Prabhu VV, Langenbach R, Becker KG, Bosetti F. Differential gene expression patterns in cyclooxygenase-1 and cyclooxygenase-2 deficient mouse brain. Genome Biol 2007; 8: R14